End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 CAD | -2.27% | -1.15% | -38.57% |
04-02 | Sernova Corp. Provides Positive Clinical and Platform Portfolio Update | CI |
03-19 | Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 130M 95.34M |
---|---|---|---|---|---|
Net income 2024 * | -31M -22.65M | Net income 2025 * | -25M -18.27M | EV / Sales 2024 * | - |
Net cash position 2024 * | 23.61M 17.25M | Net cash position 2025 * | 17.72M 12.95M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.82
x | P/E ratio 2025 * |
-3.66
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.29% |
1 day | -2.27% | ||
1 week | -1.15% | ||
Current month | -20.37% | ||
1 month | -20.37% | ||
3 months | -31.75% | ||
6 months | -41.89% | ||
Current year | -38.57% |
Managers | Title | Age | Since |
---|---|---|---|
Cynthia Pussinen
CEO | Chief Executive Officer | - | 23-09-04 |
Delfina Siroen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Frank Shannon
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Parsons
BRD | Director/Board Member | 58 | 12-04-18 |
Philip Toleikis
CTO | Chief Tech/Sci/R&D Officer | - | 09-04-27 |
Daniel Mahony
BRD | Director/Board Member | - | 22-09-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.43 | -2.27% | 96,303 |
24-04-26 | 0.44 | +3.53% | 291,510 |
24-04-25 | 0.425 | -1.16% | 79,841 |
24-04-24 | 0.43 | -3.37% | 20,000 |
24-04-23 | 0.445 | +2.30% | 53,635 |
End-of-day quote Toronto S.E., April 28, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.57% | 95.57M | |
+13.16% | 129B | |
-8.78% | 10.77B | |
+3.60% | 9.05B | |
+19.75% | 7.38B | |
+22.28% | 4.88B | |
+7.55% | 3.41B | |
-0.21% | 3.07B | |
-4.80% | 2.24B | |
-4.72% | 2.12B |
- Stock Market
- Equities
- SVA Stock